March 20, 2016
Please join us in congratulating Dr. Pengbo Zhou on receiving a one-year $500,000 grant from Highline Therapeutics.
Pengbo Zhou, PhD
Professor of Pathology and Laboratory Medicine
Professor of Pathology and Laboratory Medicine
Dr. Zhou will work with Highline Therapeutics to develop chemical inhibitors of the CUL4 E3 ubiquitin ligase and test the ability of these compounds to treat cancers with increased CUL4 activity.
Dr. Zhou worked closely with the BioPharma Alliances and Research Collaborations office at WCM (Larry Schlossman, Director) to put this agreement into place.